Clarity Medical Group Holding Limited (HKG:1406)

Revenue by Segment

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Ophthalmic Service Income	179.07M	206.52M	217.89M	215.52M	212.15M
Ophthalmic Service Income Growth	-13.29%	-5.22%	1.10%	1.59%	5.93%
Sales of Prescriptions	7.69M	7.33M	7.35M	6.86M	6.22M
Sales of Prescriptions Growth	4.99%	-0.30%	7.11%	10.25%	-0.24%
Sales of Vision Products	4.17M	-	-	-	-
Total	190.93M	213.85M	225.24M	222.38M	218.38M
Total Growth	-10.72%	-5.06%	1.28%	1.83%	5.70%

Revenue by Geography

Financials in millions HKD. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Hong Kong	190.93M	213.85M	225.24M	222.38M	218.38M
Hong Kong Growth	-10.72%	-5.06%	1.28%	1.83%	5.70%
Total	190.93M	213.85M	225.24M	222.38M	218.38M
Total Growth	-10.72%	-5.06%	1.28%	1.83%	5.70%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 18, 2026

Data Sources Report a data error